Search

Displaying results 931 - 940 of 2828 in total
  1. Drug

    Avobenzone

    go.drugbank.com/drugs/DB09495
    ApprovedInvestigational

    Avobenzone is dibenzoyl methane derivative. It is oil soluble ingredient. Avobenzone has the ability to absorb ultraviolet light over wider range of wavelengths. It is included in many commercially available sunscreens which are used as ...

    Mixtures: Safe Sea SPF 40, Sea Results Line Resolution Sea Results Line Resolution SPF30
  2. Drug

    Brentuximab vedotin

    go.drugbank.com/drugs/DB08870
    ApprovedInvestigational

    [L1737] Adcetris has also been previously approved by the FDA to treat Hodgkin's lymphoma after relapse, Hodgkin's lymphoma after stem cell transplantation when a patient has a high risk of relapse … [L1737] The ECHELON-1 study results demonstrated superior efficacy of the drug combined with a chemotherapy regimen compared to the previous standard of care.

  3. Drug

    Celtis occidentalis pollen

    go.drugbank.com/drugs/DB10472
    Approved

    Celtis occidentalis pollen is the pollen of the Celtis occidentalis plant. Celtis occidentalis pollen is mainly used in allergenic testing.

    Mixtures: Treatment Set TS333938, Treatment Set TS128872
  4. Drug

    GEM-231

    go.drugbank.com/drugs/DB05798
    Investigational

    GEM231 is a second-generation antisense oligonucleotide targeting the mRNA of the R1alpha regulatory subunit of cAMP dependent protein kinase. A monoclonal antibody combined with a toxic substance that is used treat certain types of acut...

  5. Drug

    Magnesium orotate

    go.drugbank.com/drugs/DB13786
    Experimental

    Orotic acid acts as a transporter that carries magnesium into the cells.

  6. Drug

    Nitroxoline

    go.drugbank.com/drugs/DB01422
    Experimental

    Nitroxoline is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections. It is a hydroxyquinoline derivative unrelated to other classes of drugs. Nitrox...

  7. Drug

    Montelukast

    go.drugbank.com/drugs/DB00471
    ApprovedInvestigational

    Montelukast was first approved for clinical use by the US FDA in 1998 as Merck's brand name Singulair. The medication is a member of the leukotriene receptor antagonist (LTRA) category of drugs. Although capable of demonstrating effectiv...

  8. Target

    Sodium/nucleoside cotransporter 2

    go.drugbank.com/bio_entities/BE0004781
    TransporterHumans

    Sodium-dependent and purine-selective transporter (PubMed:10087507, PubMed:9435697). … Exhibits the transport characteristics of the nucleoside transport system cif or N1 subtype (N1/cif) (selective for purine nucleosides and uridine) (PubMed:10087507, PubMed:21795683, PubMed:9435697).

    Synonyms: Concentrative nucleoside transporter 2, Sodium-coupled nucleoside transporter 2Function: azole transmembrane transporter activity
  9. Target

    Solute carrier family 23 member 2

    go.drugbank.com/bio_entities/BE0009869
    TransporterTargetHumans

    Sodium/ascorbate cotransporter (PubMed:10471399, PubMed:10556521). Mediates electrogenic uptake of vitamin C, with a stoichiometry of 2 Na(+) for each ascorbate (PubMed:10471399)

    Synonyms: Na(+)/L-ascorbic acid transporter 2, Nucleobase transporter-like 1 protein
  10. Drug

    Semotiadil

    go.drugbank.com/drugs/DB20587
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Semotiadil is a vasodilator. Semotiadil has a monoisotopic molecular weight of 536.2 Da.

    Categories: Membrane Transport Modulators